NCT06364696
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06364696
Title A Study to Find a Suitable Dose of ASP4396 in Adults With Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Astellas Pharma Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Kansas Cancer Center Westwood Kansas 66205 United States Details
START Midwest Grand Rapids Michigan 49546 United States Details
Icahn School of Medicine at Mount Sinai New York New York 10029 United States Details
University of Rochester Rochester New York 14627 United States Details
NEXT Oncology Dallas Irving Texas 75039 United States Details
START Mountain Region West Valley City Utah 84119 United States Details
NEXT Oncology Virginia Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field